Search research articles
Contact Us
Filters
Showing results (181-190 of 251) with videos related to
Page
of 26
Sort By:
Cancer Research
|
July 1, 1985
Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells
Y Pommier, L A Zwelling, C S Kao-Shan, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin
A W Nicholas, M C Wani, G Manikumar, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1997
Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors
N Neamati, A Mazumder, H Zhao, et al.
Journal of Medicinal Chemistry
|
March 17, 1995
Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study
K Raghavan, J K Buolamwini, M R Fesen, et al.
Cancer Research
|
April 1, 1993
In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes
Y H Ling, W Priebe, L Y Yang, et al.
Cancer Research
|
October 27, 1997
Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function
R G Shao, C X Cao, T Shimizu, et al.
The EMBO Journal
|
March 4, 1999
Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes
R G Shao, C X Cao, H Zhang, et al.
Cancer Research
|
October 1, 1996
Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells
F Goldwasser, T Shimizu, J Jackman, et al.
The Journal of Biological Chemistry
|
November 18, 1994
Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions
F Leteurtre, A Fujimori, A Tanizawa, et al.
AIDS Research and Human Retroviruses
|
October 6, 2000
Mutations in the HIV type 1 integrase of patients receiving long-term dideoxynucleoside therapy do not confer resistance to zidovudine
A A Pilon, C Marchand, M F Kavlick, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 251) with videos related to
Sort By:
Page
of 26
Cancer Research
|
July 1, 1985
Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells
Y Pommier, L A Zwelling, C S Kao-Shan, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Plant antitumor agents. 29. Synthesis and biological activity of ring D and ring E modified analogues of camptothecin
A W Nicholas, M C Wani, G Manikumar, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1997
Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors
N Neamati, A Mazumder, H Zhao, et al.
Journal of Medicinal Chemistry
|
March 17, 1995
Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study
K Raghavan, J K Buolamwini, M R Fesen, et al.
Cancer Research
|
April 1, 1993
In vitro cytotoxicity, cellular pharmacology, and DNA lesions induced by annamycin, an anthracycline derivative with high affinity for lipid membranes
Y H Ling, W Priebe, L Y Yang, et al.
Cancer Research
|
October 27, 1997
Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function
R G Shao, C X Cao, T Shimizu, et al.
The EMBO Journal
|
March 4, 1999
Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes
R G Shao, C X Cao, H Zhang, et al.
Cancer Research
|
October 1, 1996
Correlations between S and G2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells
F Goldwasser, T Shimizu, J Jackman, et al.
The Journal of Biological Chemistry
|
November 18, 1994
Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions
F Leteurtre, A Fujimori, A Tanizawa, et al.
AIDS Research and Human Retroviruses
|
October 6, 2000
Mutations in the HIV type 1 integrase of patients receiving long-term dideoxynucleoside therapy do not confer resistance to zidovudine
A A Pilon, C Marchand, M F Kavlick, et al.
Page
of 26